Immatics IMTX
NASDAQ IMTX
$7.59 -0.85 (-10.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immatics (IMTX) Return on Invested Capital [ROIC] (2022)

Updated

Immatics (IMTX) posted Return on Invested Capital [ROIC] of 13.18% for Q3 2022.

Analysis

Immatics (IMTX) Return on Invested Capital [ROIC] (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Immatics 1.02 Bn -1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 13.18%
API Access

Immatics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=IMTX&period=max&api_key=YOUR_API_KEY